Deerfield Management Company as of March 31, 2012
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 96 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amylin Pharmaceuticals Inc note 3.000% 6/1 | 10.2 | $194M | 194M | 1.00 | |
| Alkermes (ALKS) | 5.0 | $96M | 5.2M | 18.55 | |
| Bristol Myers Squibb (BMY) | 4.6 | $87M | 2.6M | 33.41 | |
| Pfizer (PFE) | 4.4 | $84M | 3.7M | 22.64 | |
| Onyx Pharmaceuticals Inc note 4.000% 8/1 | 3.3 | $63M | 50M | 1.26 | |
| Halozyme Therapeutics (HALO) | 3.0 | $57M | 4.4M | 12.76 | |
| Forest Laboratories | 2.9 | $54M | 1.6M | 34.69 | |
| Rigel Pharmaceuticals (RIGL) | 2.8 | $54M | 6.7M | 8.05 | |
| Medivation | 2.4 | $46M | 611k | 74.72 | |
| Nektar Therapeutics note 3.250% 9/2 | 2.2 | $43M | 43M | 1.00 | |
| Universal Health Services (UHS) | 2.2 | $41M | 983k | 41.91 | |
| Express Scripts | 2.1 | $41M | 755k | 54.18 | |
| Amylin Pharmaceuticals | 2.1 | $41M | 1.6M | 24.96 | |
| Nuvasive Inc note 2.250% 3/1 | 2.1 | $40M | 40M | 0.99 | |
| Merck & Co (MRK) | 1.9 | $37M | 950k | 38.40 | |
| Intermune Inc note 2.500% 9/1 | 1.9 | $36M | 42M | 0.86 | |
| Nuvasive Inc. conv | 1.8 | $35M | 41M | 0.86 | |
| NxStage Medical | 1.8 | $34M | 1.8M | 19.27 | |
| Teva Pharmaceutical Industries (TEVA) | 1.7 | $32M | 709k | 45.06 | |
| St. Jude Medical | 1.6 | $30M | 668k | 44.31 | |
| Heartware Intl Inc note 3.500%12/1 | 1.5 | $29M | 27M | 1.04 | |
| Hologic Inc cnv | 1.4 | $27M | 28M | 0.99 | |
| Array BioPharma | 1.4 | $26M | 7.7M | 3.41 | |
| Allscripts Healthcare Solutions (MDRX) | 1.4 | $26M | 1.6M | 16.60 | |
| AngioDynamics (ANGO) | 1.4 | $26M | 2.1M | 12.25 | |
| Brookdale Senior Living note | 1.3 | $25M | 27M | 0.94 | |
| Charles Riv Labs Intl Inc note 2.250% 6/1 | 1.3 | $25M | 25M | 1.01 | |
| Natus Medical | 1.2 | $23M | 1.9M | 11.93 | |
| Salix Pharmaceuticals | 1.2 | $23M | 440k | 52.50 | |
| Molina Healthcare (MOH) | 1.2 | $23M | 675k | 33.63 | |
| Magellan Health Services | 1.2 | $23M | 463k | 48.81 | |
| Flamel Technologies | 1.2 | $22M | 4.3M | 5.13 | |
| Walgreen Company | 1.2 | $22M | 660k | 33.49 | |
| MAP Pharmaceuticals | 1.1 | $22M | 1.5M | 14.36 | |
| Health Management Associates | 1.1 | $22M | 3.2M | 6.72 | |
| Chemed Corp New note 1.875% 5/1 | 1.1 | $21M | 21M | 1.02 | |
| Aetna | 1.1 | $21M | 426k | 50.16 | |
| Gilead Sciences (GILD) | 1.1 | $21M | 433k | 48.86 | |
| Medicines Company | 1.1 | $21M | 1.0M | 20.07 | |
| Merit Medical Systems (MMSI) | 1.0 | $20M | 1.6M | 12.42 | |
| Ardea Biosciences | 1.0 | $19M | 884k | 21.76 | |
| Par Pharmaceutical Companies | 1.0 | $19M | 490k | 38.73 | |
| WellPoint | 0.9 | $18M | 245k | 73.80 | |
| CVS Caremark Corporation (CVS) | 0.9 | $17M | 385k | 44.80 | |
| Vivus | 0.9 | $17M | 750k | 22.36 | |
| Tenet Healthcare Corporation | 0.9 | $17M | 3.1M | 5.31 | |
| Shire | 0.8 | $14M | 151k | 94.75 | |
| Rockwell Medical Technologies | 0.7 | $13M | 1.3M | 9.46 | |
| CONMED Corporation (CNMD) | 0.6 | $12M | 411k | 29.87 | |
| Hill-Rom Holdings | 0.5 | $10M | 310k | 33.41 | |
| Greatbatch Inc sdcv 2.250% 6/1 | 0.5 | $10M | 10M | 1.00 | |
| Cempra | 0.4 | $8.2M | 1.1M | 7.55 | |
| BioScrip | 0.4 | $7.4M | 1.1M | 6.79 | |
| Cytokinetics | 0.4 | $7.1M | 6.1M | 1.15 | |
| Cardiovascular Systems | 0.4 | $6.8M | 739k | 9.25 | |
| Pacific Biosciences of California (PACB) | 0.4 | $6.9M | 2.0M | 3.42 | |
| Oncothyreon | 0.3 | $6.5M | 1.5M | 4.36 | |
| Incyte Corporation (INCY) | 0.3 | $6.3M | 325k | 19.30 | |
| Ym Biosciences | 0.3 | $5.9M | 3.2M | 1.86 | |
| Questcor Pharmaceuticals | 0.3 | $5.6M | 150k | 37.62 | |
| DUSA Pharmaceuticals | 0.3 | $5.7M | 912k | 6.26 | |
| Metropolitan Health Networks | 0.2 | $4.7M | 500k | 9.37 | |
| Universal American | 0.2 | $4.5M | 420k | 10.78 | |
| AVANIR Pharmaceuticals | 0.2 | $4.4M | 1.3M | 3.42 | |
| Santarus | 0.2 | $4.3M | 730k | 5.85 | |
| NPS Pharmaceuticals | 0.2 | $3.9M | 571k | 6.84 | |
| Amarin Corporation (AMRN) | 0.2 | $3.6M | 320k | 11.32 | |
| Anthera Pharmaceuticals | 0.2 | $3.2M | 1.4M | 2.21 | |
| Novadaq Technologies | 0.2 | $3.3M | 503k | 6.55 | |
| Orexigen Therapeutics | 0.1 | $2.5M | 606k | 4.10 | |
| Alere Inc note 3.000% 5/1 | 0.1 | $2.5M | 2.5M | 1.00 | |
| Newlink Genetics Corporation | 0.1 | $2.5M | 275k | 9.15 | |
| DepoMed | 0.1 | $2.2M | 355k | 6.26 | |
| Palatin Technologies | 0.1 | $2.2M | 3.0M | 0.73 | |
| Corcept Therapeutics Incorporated (CORT) | 0.1 | $2.1M | 540k | 3.93 | |
| Edwards Lifesciences (EW) | 0.1 | $1.8M | 25k | 72.72 | |
| Capital Senior Living Corporation | 0.1 | $1.9M | 210k | 9.24 | |
| Discovery Laboratories | 0.1 | $1.6M | 614k | 2.68 | |
| Acelrx Pharmaceuticals | 0.1 | $1.5M | 436k | 3.49 | |
| Exelixis (EXEL) | 0.1 | $1.3M | 245k | 5.18 | |
| Transcept Pharmaceuticals | 0.1 | $1.3M | 128k | 10.52 | |
| Regeneron Pharmaceuticals (REGN) | 0.0 | $700k | 6.0k | 116.67 | |
| Rite Aid Corporation | 0.0 | $737k | 423k | 1.74 | |
| Chelsea Therapeutics International | 0.0 | $789k | 308k | 2.56 | |
| Antares Pharma | 0.0 | $669k | 207k | 3.23 | |
| Biolase Technology | 0.0 | $769k | 284k | 2.71 | |
| Protalix BioTherapeutics | 0.0 | $558k | 88k | 6.37 | |
| HMS Holdings | 0.0 | $478k | 15k | 31.24 | |
| Tengion (TNGN) | 0.0 | $594k | 1.1M | 0.56 | |
| Stryker Corporation (SYK) | 0.0 | $416k | 7.5k | 55.47 | |
| Biogen Idec (BIIB) | 0.0 | $315k | 2.5k | 126.00 | |
| Zimmer Holdings (ZBH) | 0.0 | $321k | 5.0k | 64.20 | |
| Elan Corporation | 0.0 | $339k | 23k | 15.00 | |
| Athersys | 0.0 | $374k | 242k | 1.55 | |
| BSD Medical Corporation | 0.0 | $56k | 27k | 2.05 | |
| Neurometrix | 0.0 | $29k | 39k | 0.74 |
